Philips North America has been the subject of 369 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for Bard Peripheral Vascular Inc.
Bard Peripheral Vascular Inc: 0 warning letters, 1 recall, 0 approval records, 0 Form 483s.
Philips North America: 0 warning letters, 369 recalls, 0 approval records, 0 Form 483s.
Side by side
Bard Peripheral Vascular Inc — Warning letters0
Philips North America — Warning letters0
Bard Peripheral Vascular Inc — Recalls1
Philips North America — Recalls369
Bard Peripheral Vascular Inc — Approval records0
Philips North America — Approval records0
Bard Peripheral Vascular Inc — Form 483s0
Philips North America — Form 483s0
Timeline
Cite this comparison
Pre-formatted for a story, footnote, or reference list:
"Bard Peripheral Vascular Inc vs Philips North America: FDA Enforcement Comparison." Argus HQ, accessed October 13, 2026. https://argushq.ai/compare/bard-peripheral-vascular-inc-vs-philips-north-america
Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗